Abstract:Clustering of glial cells around amyloid‐β plaques is a well‐known hallmark of Alzheimer's disease (AD) neuropathology, but it is unclear what triggers this glial response and whether the response is beneficial or detrimental. This study investigates clustering and phenotype of glial cells around neuritic plaques (NP) and non‐neuritic plaques (non‐NP) during the progression of Alzheimer's disease neuropathologic change (ADNC). We demonstrate that microglia and astrocytes preferentially cluster around p‐tau+ NP with brain region‐specific differences between hippocampus and frontal cortex. This close association of the neuroimmune response with NP during ADNC progression underscores the central role of NP in AD. Neuroinflammation plays an important role in the pathological cascade of Alzheimer's disease (AD) along with aggregation of extracellular amyloid‐β (Aβ) plaques and intracellular aggregates of tau protein. In animal models of amyloidosis, local immune activation is centered around Aβ plaques, which are usually of uniform morphology, dependent on the transgenic model used. In postmortem human brains a diversity of Aβ plaque morphologies is seen including diffuse plaques (non‐neuritic plaques, non‐NP), dense‐core plaques, cotton‐wool plaques, and NP. In a recent study, we demonstrated that during the progression of Alzheimer's disease neuropathologic changes (ADNC), a transformation of non‐NP into NP occurs which is tightly linked to the emergence of cortical, but not hippocampal neurofibrillary tangle (NFT) pathology. This highlights the central role of NP in AD pathogenesis as well as brain region‐specific differences in NP formation. In order to correlate the transformation of plaque types with local immune activation, we quantified the clustering and phenotype of microglia and accumulation of astrocytes around non‐NP and NP during the progression of ADNC. We hypothesize that glial clustering occurs in response to formation of neuritic dystrophy around NP. First, we show that Iba1‐positive microglia preferentially cluster around NP. Utilizing microglia phenotypic markers, we furthermore demonstrate that CD68‐positive phagocytic microglia show a strong preference to cluster around NP in both the hippocampus and frontal cortex. A similar preferential clustering is observed for CD11c and ferritin‐positive microglia in the frontal cortex, while this preference is less pronounced in the hippocampus, highlighting differences between hippocampal and cortical Aβ plaques. Glial fibrillary acidic protein‐positive astrocytes showed a clear preference for clustering around NP in both the frontal cortex and hippocampus. These data support the notion that NP are intimately associated with the neuroimmune response in AD and underscore the importance of the interplay of protein deposits and the immune system in the pathophysiology of AD.

Association of region-specific hippocampal reduction of neurogranin with inflammasome proteins in post mortem brains of Alzheimer's disease

Neurogranin in Alzheimer's disease and ageing: A human post-mortem study

The Association of Enlarged Perivascular Space with Microglia-Related Inflammation and Alzheimer's Pathology in Cognitively Normal Elderly

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer's Disease

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease

Association of Cerebrospinal Fluid Neurogranin Levels with Cognition and Neurodegeneration in Alzheimer's Disease

Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention

Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer's disease

Identification of immunogenic cell death-related genes involved in Alzheimer's disease

From Pathophysiology to Clinical Implications

CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis

Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

Preferential clustering of microglia and astrocytes around neuritic plaques during progression of Alzheimer's disease neuropathological changes

Systemic Inflammasome Activation and Pyroptosis Associate with the Progression of Amnestic Mild Cognitive Impairment and Alzheimer's Disease.

Association between hippocampal microglia, AD and LATE‐NC, and cognitive decline in older adults

Extracellular vesicles mediate inflammasome signaling in the brain and heart of Alzheimer's disease mice

Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer's Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up